Filters

Choristoneura fumiferana nuclear polyhedrosis virus Major envelope glycoprotein (GP67)

Choristoneura fumiferana nuclear polyhedrosis virus Major envelope glycoprotein (GP67) size: 1000ug 2310

Supplier MBS RECOMBINANT PROTEINS
Price 2310
Size 1000ug
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long nameRecombinant Choristoneura fumiferana nuclear polyhedrosis virus Major envelope glycoprotein (GP67)
Alternative names Major envelope glycoprotein, gp67, major budded virus envelope glycoprotein, major budded virus envelope glycoprotein
Gene nameN/A
Other gene names GP67, P67, CfMNPVgpORF119
General description All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, coli, Major envelope glycoprotein (GP67) is a recombinant protein expressed in E
Product categoryRecombinant Proteins
Expression system coli, E
Available also expressed in: Yeast, E Coli
PurityGreater than 90% (determined by SDS-PAGE)
Form We can custom produce according to your specifications, This item requires custom production and lead time is between 5-9 weeks
Storage Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius
Applications IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA
Gene targetChoristoneura fumiferana polyhedrosis virus Major envelope glycoprotein (GP67)
Short nameChoristoneura fumiferana polyhedrosis virus Major envelope glycoprotein (GP67)
Alternative nameChoristoneura fumiferana nuclear polyhedrosis virus Major envelope glycoprotein (GP67)

Similar products

Subscribe to our Newsletter